Endocarditis Disease

BASICS

DESCRIPTION
A disease resulting from infection primarily of the valvular endocardium and occasionally the mural endocardium
  • Acute endocarditis: Aggressive course, usually caused by more virulent organisms, such as Staphylococcus aureus, group B streptococcus, may not have underlying valve lesion
  • Subacute endocarditis: Indolent course, usually caused by alpha-hemolytic streptococci, enterococci (usually in setting of underlying structural valve disease)
  • Endocarditis in intravenous drug abusers: Commonly involves the tricuspid valve. Staphylococcus aureus is the most common infecting organism.
  • Early prosthetic valve endocarditis: Occurs within 60 days of valve implantation. Staphylococci, gram-negative bacilli and Candida are common infecting organisms.
  • Late prosthetic valve endocarditis: Occurs 60 days or longer after valve implantation. Staphylococcus epidermidis, alpha-hemolytic streptococci and enterococci are common infecting organisms.
  • System(s) affected: Cardiovascular, Skin/Exocrine, Pulmonary, Endocrine/Metabolic, Renal/Urologic, Hemic/Lymphatic/Immunologic
  • Genetics: Unknown
  • Incidence/Prevalence in USA: 1.7-4.2/100,000; 0.32-1.3/1000 hospital admissions
  • Predominant age: All ages
  • Predominant sex: Male > Female (slightly)
SIGNS AND SYMPTOMS
  • Fever, may be high, low or absent. May be only symptom in prosthetic valve endocarditis.
  • Night sweats, chilly sensation
  • Malaise, myalgia, joint pain
  • Back pain, may be severe
  • Anorexia, weight loss
  • Stiff neck
  • Delirium, headache
  • Paralysis, hemiparesis, aphasia
  • Numbness, muscle weakness
  • Cold extremity with pain
  • Bloody urine, may be gross or microscopic
  • Bloody sputum, from septic pulmonary emboli
  • Petechiae
  • Conjunctival hemorrhage
  • Hemorrhagic or necrotic pustule
  • Pain of finger tip, or toe tip (subjective symptom of Osler node)
  • Chest pain, shortness of breath, cough
  • Pallor
  • Roth spot
  • Osler node
  • Janeway lesion
  • Heart murmur, may be absent
  • Neck vein distention
  • Gallops
  • Rales
  • Cardiac arrhythmia
  • Pericardial rub
  • Pleural friction rub
  • Splenomegaly
CAUSES
  • Staphylococcus aureus is a causative organism in all types of endocarditis, especially acute endocarditis and endocarditis seen in IV drug abusers
  • Acute endocarditis
    • Staphylococcus aureus
    • Streptococcus groups A, B, C, G
    • Haemophilus influenzae
    • Haemophilus parainfluenzae
    • Streptococcus pneumoniae
    • Staphylococcus lugdunensis
    • Enterococcus species
    • Neisseria gonorrhoeae
  • Subacute endocarditis
    • Alpha-hemolytic streptococci (viridans streptococci)
    • Streptococcus bovis
    • Enterococcus species (E. faecalis, E. faecium, E. durans)
    • Haemophilus aphrophilus and H. paraphrophilus
    • Actinobacillus actinomycetemcomitans
    • Cardiobacterium hominis
    • Eikenella corrodens
    • Kingella kingae
    • Staphylococcus aureus
  • Endocarditis in intravenous drug-abusers
    • Staphylococcus aureus
    • Pseudomonas aeruginosa
    • Burkholderia cepacia
    • Other gram-negative bacilli
    • Enterococcus species
    • Candida species
  • Early prosthetic valve endocarditis
    • Staphylococcus aureus
    • Staphylococcus epidermidis
    • Gram-negative bacilli
    • Candida species
    • Aspergillus species
  • Late prosthetic valve endocarditis
    • Alpha-hemolytic streptococci (viridans streptococci)
    • Enterococcus species
    • Staphylococcus epidermidis
    • Candida species
    • Aspergillus species
  • Culture-negative endocarditis
    • 5-10% of cases are culture-negative
    • Patients on antibiotics
    • Bartonella quintana (homeless people)
    • Bartonella henselae (cat owners)
    • Brucella
    • Fungi
    • Coxiella burnetii (Q fever)
    • Chlamydia trachomatis
    • Chlamydia psittaci
RISK FACTORS
  • Conditions predisposed to development of endocarditis
    • Prosthetic cardiac valves, including bioprosthetic and homograft valves
    • Previous bacterial endocarditis, even in the absence of heart disease
    • Most congenital cardiac malformations
    • Rheumatic and other acquired valvular dysfunction, even after valvular surgery
    • Hypertrophic cardiomyopathy
    • Mitral valve prolapse with valvular regurgitation
    • Indwelling intravascular devices
  • Dental or surgical procedures that may cause transient bacteremia leading to endocarditis in susceptible hosts
    • Dental procedures known to produce gingival irritation, including professional cleaning
    • Tonsillectomy and/or adenoidectomy
    • Surgical operations that involve intestinal or respiratory mucosa
    • Bronchoscopy with a rigid bronchoscope
    • Sclerotherapy for esophageal varices
    • Esophageal dilatation
    • Gallbladder surgery
    • Cystoscopy
    • Urethral dilatation
    • Urethral catheterization if urinary tract infection is present
    • Urinary tract surgery if urinary tract infection is present
    • Prostatic surgery
    • Incision and drainage of infected tissue
    • Vaginal hysterectomy
    • Vaginal delivery in the presence of infection

DIAGNOSIS

LABORATORY
  • Positive blood cultures taken at different times
  • 2-dimensional echocardiography, not always positive for vegetations (transesophageal echocardiography has high sensitivity)
  • Leukocytosis in acute endocarditis
  • Anemia in subacute endocarditis
  • Elevated erythrocyte sedimentation rate
  • Decreased C3, C4, CH50 in subacute endocarditis
  • Hematuria, microscopic or macroscopic
  • Rheumatoid factor in subacute endocarditis
  • Serologies for Chlamydia, Q fever (Coxiella) and Bartonella may be useful in "culture-negative" endocarditis

Drugs that may alter lab results: Antibiotics may make blood cultures falsely negative
Disorders that may alter lab results:

  • Endocarditis caused by fungi, Chlamydia trachomatis, Chlamydia psittaci, Coxiella burnetii, Bartonella species may be associated with negative blood cultures
  • Prolonged incubation of blood cultures is needed in endocarditis caused by fastidious organisms, e.g., HACEK organisms (Haemophilus species, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, Kingella species), Brucella species
PATHOLOGICAL FINDINGS
  • Vegetations on the affected endocardium are composed of platelets, fibrin and colonies of micro-organisms. Destruction of valvular endocardium, perforation of valve leaflets, rupture of chordae tendineae, abscesses of myocardium, rupture of sinus of Valsalva, pericarditis may occur.
  • Emboli and/or infarction may be found in different body organs. Abscesses and micro-abscesses may be found in different organs. Kidneys may show embolic and/or immune-complex glomerulonephritis.
SPECIAL TESTS
N/A
IMAGING
  • Pulmonary ventilation perfusion scan may be useful in right-sided endocarditis
  • Computerized axial tomographic scan may be useful in locating abscesses
DIAGNOSTIC PROCEDURES
  • Transesophageal echocardiography is useful, especially in prosthetic or bioprosthetic valve endocarditis and S. aureus endocarditis associated with intravascular catheter
  • Cardiac catheterization may be indicated to ascertain the degree of valvular damage
  • Aortic root injection may be useful when aortic root abscess or rupture of sinus of Valsalva is suspected
  • Duke criteria for diagnosis of infective endocarditis
    • 2 major criteria, or
    • 1 major and 3 minor criteria, or
    • 5 minor criteria
  • Major criteria
    • Positive blood culture
      • Typical microorganism for infective endocarditis from 2 separate blood cultures: Viridans streptococci, Streptococcus bovis, HACEK group, or community acquired Staphylococcus aureus or enterococci, in the absence of a primary focus, or
      • Persistently positive blood culture. Defined as recovery of a microorganism consistent with infective endocarditis from: blood cultures drawn more than 12 hours apart, or all of 3 or a majority of 4 or more separate blood cultures, with first and last drawn at least 1 hour apart
    • Evidence of endocardial involvement
      • Positive echocardiogram: (a) oscillating intracardiac mass, on valve or supporting structures, or in the path of regurgitant jets, or on implanted material, in the absence of an alternative anatomic explanation, or (b) abscess, or (c) new partial dehiscence of prosthetic valve
      • New valvular regurgitation (increase or change in pre-existing murmur not sufficient)
  • Minor criteria
    • Predisposition: predisposing heart condition or intravenous drug use
    • Fever ≥ 38.0°C (100.4°F)
    • Vascular phenomena: major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhage, Janeway lesions
    • Immunologic phenomena: glomerulonephritis, Osler's nodes, Roth spots, rheumatoid factor
    • Microbiologic evidence: positive blood culture, but not meeting major criterion as noted previously or serologic evidence of active infection with organism consistent with infective endocarditis
    • Echocardiogram: consistent with infective endocarditis but not meeting major criterion as previous noted

TREATMENT

APPROPRIATE HEALTH CARE
  • Initial hospitalized care
  • Intensive care may be needed in critically ill patients
  • Outpatient home intravenous antibiotic therapy may be utilized in selected patients who are stable and reliable
GENERAL MEASURES
  • Treatment for congestive heart failure if it occurs
  • Oxygen treatment may be indicated
  • Hemodialysis may be used in patients who develop renal failure
SURGICAL MEASURES
  • Cardiac surgery to replace infected valve may be performed before antibiotic treatment course is completed when:
    • There is evidence of congestive heart failure due to valve incompetence, or
    • Multiple major systemic emboli have occurred, or
    • The infection is caused by resistant organisms, e.g., fungus, Pseudomonas aeruginosa, or
    • There is dehiscence of infected prosthetic valve, or
    • There is relapse of prosthetic valve endocarditis, or
    • There is persistent bacteremia despite antibiotic treatment
ACTIVITY
  • Bedrest is indicated initially
  • Ambulation when clinically improved
DIET

No special diet

PATIENT EDUCATION
  • Instruct patient regarding importance of dental hygiene
  • Emphasize to patient that it is important to take antibiotic prophylaxis when undergoing certain dental/surgical procedures
  • Give the patient an AHA wallet card listing antibiotic regimens for prophylaxis. Obtain the AHA wallet card, 78-1005 (CP), from local chapters of American Heart Association.

FOLLOW UP

PREVENTION/AVOIDANCE
  • Dental caries should be treated while the patient is being treated for endocarditis
  • Patients should maintain good oral hygiene
  • Antibiotic prophylaxis should be given to the patient who is undergoing dental or surgical procedures that may cause transient bacteremia
  • Standard antibiotic regimen for dental/oral/upper respiratory tract procedures: (may be used in patients with prosthetic valves)
    • Amoxicillin 2 g orally 1 h before procedure
    • For patients who are allergic to penicillin: Clindamycin 600 mg orally 1 h before a procedure
  • Alternate antibiotic regimens for dental/oral/upper respiratory tract procedures
    • For patients unable to take oral medications: Ampicillin 2.0 g IV (or IM) 30 minutes before procedure
    • For patients who are allergic to penicillin: Clindamycin 600 mg IV 30 minutes before a procedure
  • Standard antibiotic regimen for genitourinary/gastrointestinal procedures
    • Ampicillin 2.0 g IV (or IM) plus gentamicin 1.5 mg/kg IV (or IM) (not to exceed 120 mg) 30 minutes before procedure
    • For patients who are allergic to penicillin: Vancomycin 1.0 g IV infused over one hour plus gentamicin 1.5 mg/kg IV (or IM) (not to exceed 120 mg); complete infusion 30 minutes before procedure
  • Alternate oral regimen for moderate-risk patients undergoing genitourinary/gastrointestinal procedures
    • Amoxicillin 2.0 g orally one hour before procedure or Ampicillin 2 g IV (or IM) 30 minutes before procedure
    • For patients who are allergic to penicillin: Vancomycin 1.0 g IV infused over 1 hour; complete infusion 30 minutes before procedure
POSSIBLE COMPLICATIONS
  • Congestive heart failure
  • Ruptured valve cusp
  • Sinus of Valsalva aneurysm
  • Aortic root abscesses
  • Myocardial abscesses
  • Myocardial infarction
  • Pericarditis
  • Cardiac arrhythmia
  • Meningitis
  • Cerebral emboli
  • Brain abscesses
  • Ruptured mycotic aneurysm
  • Septic pulmonary infarcts
  • Splenic infarcts
  • Arterial emboli and infarcts
  • Arthritis
  • Myositis
  • Glomerulonephritis
  • Acute renal failure
  • Mesenteric infarct
EXPECTED COURSE AND PROGNOSIS
  • In staphylococcal endocarditis, fever and positive blood cultures may persist up to 10 days after appropriate treatment started
  • In streptococcal endocarditis, there should be clinical response within 48 hours of antibiotic treatment and blood cultures should be negative soon after antibiotic treatment is started
  • Prognosis depends largely on the possible complications

MISCELLANEOUS

ASSOCIATED CONDITIONS

Most patients who have tricuspid valve endocarditis are intravenous drug abusers or have indwelling IV lines

AGE-RELATED FACTORS

Pediatric: N/A
Geriatric: Prognosis is worse in elderly people
Others: N/A

PREGNANCY

Gentamicin should be used with caution; avoid use if possible

OTHER NOTES
  • Gentamicin dosing: 3 mg/kg/day in divided doses every 8-12 hours, depending on renal function and results of peak/trough measures.
ABBREVIATIONS

IE = Infective endocarditis
ABE = Acute bacterial endocarditis
SBE = Subacute bacterial endocarditis

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.